Malignant lymphoma encompasses a wide variety of distinct disease entities. It is generally
more common in developed countries and less common in developing countries. The East …

Diffuse large B-cell lymphoma (DLBCL) is stratified into prognostically favorable germinal
center B-cell (GCB)–like and unfavorable activated B-cell (ABC)–like subtypes based on gene …

Purpose Patients with natural killer T (NK/T) -cell lymphomas have poor survival outcome,
and for this condition there is no optimal therapy. The purpose of this study was to design a …

Epstein-Barr virus (human herpesvirus-4) is very common virus that can be detected in more
than 95% of the human population. Most people are asymptomatic and live their entire lives …

PURPOSE: On the basis of the benefits of frontline radiation in early-stage, extranodal,
natural killer (NK)/T-cell lymphoma (ENKTL), we conducted a phase II trial of concurrent …

TP53 mutation is an independent marker of poor prognosis in patients with diffuse large B-cell
lymphoma (DLBCL) treated with cyclophosphamide, hydroxydaunorubicin, vincristine, …

CD30, originally identified as a cell-surface marker of Reed-Sternberg and Hodgkin cells of
classical Hodgkin lymphoma, is also expressed by several types of non-Hodgkin lymphoma, …

Aims In this study, we examined BRAF mutation in a wide range of histiocytic and dendritic
cell neoplasms and compared its detection rate in each disease group. Methods and results …

The aim of this retrospective cohort study was to analyze the impact of surgery on the
outcomes and qualities of life (QOL) in patients with intestinal diffuse large B-cell lymphoma (…

Compared with the West, the overall incidence of lymphoid neoplasms is lower, and the
subtype distribution is distinct in Asia. To comprehensively investigate the subtype distribution …